Hims & Hers Takes On Novo Nordisk: What We Know Right Now

By Travis Hoium – Feb 5, 2026 at 4:53PM EST

NYSE: HIMS

Hims & Hers Health

Market Cap

$5.6B

Today's Change

(-3.67%) $0.90

Current Price

$23.50

Price as of February 5, 2026 at 3:58 PM ET

Hims & Hers fell on fear that Novo Nordisk would take action against the company's new oral GLP-1, but there's more to the story.

Hims & Hers (HIMS 3.67%) introduced a new oral GLP-1 product this morning only weeks after Novo Nordisk's (NVO 8.16%) hit oral version of Wegovy hit the market. And the pharma giant wasn't happy with what they heard.

Ad the day has gone on we've learned more about how Hims & Hers may be producing a compounded version of this GLP-1 and how it'll use a legal loophole to keep the product in the market, just like it did with injectable GLP-1s.

*Stock prices used were end-of-day prices of Feb. 5, 2026. The video was published on Feb. 5, 2026.

Travis Hoium is a contributing Motley Fool stock market analyst covering solar energy, technology, and growth stocks. Before The Motley Fool, Travis was a mechanical engineer at 3M and founded a virtual reality company. He holds a bachelor’s degree in mechanical engineering and a master’s degree in business administration from the University of Minnesota.

TMFFlushDraw

@travishoium